Navigating the school year with type 1 diabetes: A call to support and action
A T1D dad and physician's POV about the start of a new school year.
ADA Takeaways: Day 2
At the ADA Scientific Sessions, scientists will present the latest T1D research, all with the goal of improving lives for the T1D community.
Breakthrough T1D spearheads the formation of monitoring guidelines
We spearheaded an effort to develop the first internationally agreed-upon guidance for anyone who tests positive for T1D autoantibodies.
ADA Takeaways: Day 1
At the ADA Scientific Sessions, scientists will present the latest T1D research, all with the goal of improving lives for the T1D community.
Powering research breakthroughs
We invest in the most promising research to turn ideas into life-changing therapies and lead the way to cures.
Breakthrough T1D heads to ADA’s 84th Scientific Sessions
Breakthrough T1D researchers will gather at the ADA conference and present new study results and clinical trials for T1D.
Diagnosed days before hosting 100K country music fans
Sarah Trahern is CEO of the Country Music Association (CMA). Read her T1D story.
We are Breakthrough T1D
As the leading global type 1 diabetes (T1D) research and advocacy organization, we’re here to make every day life with T1D better.
C-Peptide as an Endpoint in Clinical Trials: Its Time Has Come
A new publication provides more evidence for C-peptide as a validated surrogate to predict clinical benefits of disease-modifying therapies in T1D.
A New Shot on Goal for Cell Therapies In T1D
Eledon Pharmaceuticals announces new funding from the T1D Fund and the launch of their clinical trial for tegoprubart in T1D.
